Catalyst Wire Dossier Catalyst Wire Dossier

H1N1 influenza vaccine, adjuvanted

influenza vaccine, H1N1, adjuvanted · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H1N1 influenza vaccine, adjuvanted, covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10 [Phase 2]

See pricing